相关实验视频

Updated: Jan 17, 2026

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Published on: June 16, 2019

一个没有异种的红细胞分化公式模型状细胞疾病从体质来源的患者iPSCs

Ashlee J Conway¹, Tolulope O Rosanwo², Thomas E Williamson³

¹Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Experimental hematology

|September 16, 2025

概括

人类衍生诱导多能干细胞 (iPSC) 被分化为成熟的红细胞 (RBC),用于研究状细胞疾病 (SCD). 这种优化的协议产生了针对患者的红细胞,为SCD研究和治疗开发提供了一个新的体外模型.

科学领域:

干细胞生物学干细胞生物学
血液学血液学血液学
组织工程是组织工程.

背景情况:

人类诱导的多能干细胞 (iPSCs) 具有组织工程的多系潜力.
使用iPSCs模拟红细胞 (RBC) 疾病,如状细胞疾病 (SCD),由于红细胞的生长不成熟,因此具有挑战性.

研究的目的:

开发一个优化的协议,使iPSCs分化为成熟的无核红细胞.
创建一个针对患者的体外模型来研究SCD并确定治疗点.

主要方法:

采用了优化的三阶段红球分化协议.
诱导红细胞 (iRBCs) 的特征是表型和血红蛋白表达.
在iPSC衍生的SCD网红细胞上进行了RNA测序.
该协议被改进为使用聚乙烯醇 (PVA) 的无异配方.

主要成果:

该方案成功地从健康的捐赠者和SCD患者中生成了无核,表达β-环球蛋白的红细胞.
在低氧条件下,SCDiRBCs在低氧条件下表现出状表型.
RNA测序揭示了与SCD相关的调节失调的分子通路.
无异种成分的配方显著提高了iRBC的产生,而不会影响成熟.

结论:

来自iPSCs的患者特异性iRBCs为SCD研究提供了宝贵的体外工具.
这种模型有助于研究疾病机制和开发新的治疗策略.
优化后的,无外基因的协议提高了iPSC衍生的红细胞的效率和适用性.

更多相关视频

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

Published on: September 6, 2018

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...